Figure 1.

Disposition of patients and study population. ADA, adapalene; BPO, benzoyl peroxide; CLNP, clindamycin phosphate; ITT, intent‐to‐treat.

Disposition of patients and study population. ADA, adapalene; BPO, benzoyl peroxide; CLNP, clindamycin phosphate; ITT, intent‐to‐treat.